Skip to content

Exercise Induced Changes in Fat Metabolism

Exercise-mediated Changes in Adipocyte Differentiation and Metabolic Function

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02581306
Acronym
BC
Enrollment
29
Registered
2015-10-20
Start date
2015-10-31
Completion date
2016-05-11
Last updated
2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers

Brief summary

If eligible to participate in the research study after completing the physical screening procedures, participants will be asked to return to the Substrate Metabolism Laboratory on another occasion after a short fast (no food or beverages - besides water) for at least 6 hours. After participants arrive, participants will rest quietly for approximately 30 min. The investigators will then collect a blood sample from a vein in participants hand, or forearm. After obtaining a baseline blood sample, participants will exercise at a moderate intensity (on a treadmill or a stationary bike) for one hour. This one hour moderate exercise session will feel like a slow jog during which participants would be able to carry a conversation. In order for the investigators to measure energy expended and the amount of fat participants are burning during exercise, the investigators will periodically ask participants to breathe through a mouthpiece so the investigators can collect participants expired breath. After the exercise session the investigators will collect another blood sample from a vein in participants hand, or forearm.

Detailed description

General study design * Subjects who exercise regularly will be instructed to exercise exactly 3 days before the experimental trial, and then abstain from their exercise training program until after the experiment is complete. * Subjects will arrive to the Substrate Metabolism Laboratory (1210 CCRB) after at least a 6h fast. * After resting quietly in the laboratory for approximately 30min, Dr. Horowitz will collect a resting blood sample by venipuncture, as he has done in our other IRB approved protocols (e.g., HUM00029179). Briefly, Dr. Horowitz will wash his hands and put on gloves. The participant's skin will be disinfected at the venipuncture site with isopropyl alcohol. Single-use needles will be used for each participant and immediately discarded into a biohazard sharps container after use. After the blood draw, direct pressure will be applied to the site of needle insertion to avoid/reduce bruising and discomfort. * Subjects will exercise (bike or treadmill) for 1h at a moderate exercise intensity (approximately 65% of their predicted VO2peak). This moderate exercise intensity has been used extensively by Dr. Horowitz's laboratory in previous exercise testing and training studies in both lean and obese individuals, and is well tolerated by both populations. * During the exercise session, subjects will wear a heart rate monitor to ensure participants are exercising at the correct exercise intensity. * Subjects will also use the mouthpiece and nose clip (described above) for \ 5min at the beginning, middle, and end of exercise to verify they are exercising at approximately 65% of their predicted VO2peak. * A study team member will be present with the participant at all times during exercise to ensure the comfort and safety. * Immediately after exercise another blood sample will be collected.

Interventions

There is no drug or device intervention in this study. Subjects will exercise at a moderate intensity for 60 minutes and a blood sample will be obtained before and after the exercise session

Sponsors

University of Michigan
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Age: 18-40 * Body Mass Index: 20-35 kg/m2 * Women must have regularly occurring menses and must be premenopausal

Exclusion criteria

* Pregnant or lactating * Evidence/history of cardiovascular or metabolic disease * Medications known to affect lipid or glucose metabolism

Design outcomes

Primary

MeasureTime frameDescription
changes in plasma concentrations of epinephrine after a session of exercise1 dayPlasma levels will be measured using appropriate commercially available assays.
changes in plasma concentrations of lactate after a session of exercise1 dayPlasma levels will be measured using appropriate commercially available assays.
changes in plasma concentrations of fatty acids after a session of exercise1 dayPlasma levels will be measured using appropriate commercially available assays.
changes in plasma concentrations of IL-6 after a session of exercise1 dayPlasma levels will be measured using appropriate commercially available assays.
changes in plasma concentrations of irisin after a session of exercise1 dayPlasma levels will be measured using appropriate commercially available assays.
changes in plasma concentrations of growth hormone after a session of exercise1 dayPlasma levels will be measured using appropriate commercially available assays.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026